Ledger.Open graph →
SEC Form D · Amendment · filed November 18, 2019

Gala Therapeutics, Inc

Offering
$43.0M
Sold
$42.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MENLO PARK, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (5)

Jonathan Waldstreicher · Menlo Park, CAExec · DirectorNicholas Cayer · Cromwell, CTExec · DirectorSeth Harrison · Cambridge, MADirectorCury Maia BTG Pactual Global Asset Management Limited · New York, NYExec · DirectorSeth Harrison · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗